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| BACKGROUND
Interleukin (IL)-21 is a four-helix bundle cytokine mainly produced by activated CD4+ T cells and natural killer (NK) T cells. [1] IL-21 signals through IL-21 receptor (IL-21R), impacting cellular proliferation, differentiation, cytokine production and T-cell effector function. [2] IL-21R is expressed by various skin cells, including T cells (both CD4+ and CD8+), B cells and keratinocytes. [3] IL-21 is thought to contribute to the induction and maintenance of psoriasis. [4] [5] [6] [7] IL-21 promotes T helper (Th) 17 cell differentiation, inhibits transforming growth factor (TGF)-beta-driven differentiation of Foxp3+ regulatory T cells (Tregs) and allows CD4+ Th cells to become resistant to the suppressive effects of Tregs. [5, 6, [8] [9] [10] [11] [12] IL-21 level was higher in psoriasis lesional skin than non-lesional skin and healthy controls. Elevated serum IL-21 in psoriasis patients positively correlated with disease severity. [9, 13, 14] However, how IL-21 participates in psoriasis pathogenesis is still unclear. Although intradermal IL-21 injection induced psoriasis-like manifestations in mice, it was independent of IL-17, which is a key player of human psoriasis. [15, 16] IL-21-sustained excessive growth of keratinocytes in psoriasis was not mediated by IL-22, which is involved in keratinocyte proliferation. [17, 18] IFN-γ + CD4 + T cells instead of IL-17A + Th17 cells mediated IL-21-induced acanthosis.
[16]
| QUESTIONS ADDRESSED
We aimed to understand the role of IL-21R-mediated signalling in imiquimod (IMQ)-induced psoriasiform dermatitis model using IL-21R
gene-deficient (IL-21R
−/− ) mice.
| EXPERIMENTAL DESIGN
We topically applied IMQ to the ear of wild-type (WT) and IL-21R
−/− mice for consecutive 6 days. Ear skin was evaluated for macroscopic and microscopic features of psoriasis, and gene expression of (i) Th17
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cytokines (IL-17A and IL-22), (ii) Th17-driving cytokine IL-23/p19 and (iii) keratinocyte proliferation marker keratin (KRT) 16 using qRT-PCR. 
| RESULTS
Following topical IMQ treatment in WT mice, IL-21 was increased as early as day 1 with a second peak at day 5 ( Figure S1 ). Th17-associated cytokines (IL-17A, IL-22, IL-23/p19) and KRT16 began to increase at day 1 and were highest at day 5. As IL-21 was the first cytokine to be Th17 cells, [19] [20] [21] and IL-17-producing γδ T cells have similarities to
Th17 cells in that they also express CC-chemokine receptor 6 (CCR6), IL-23R and retinoic acid receptor-related orphan receptor-γt (RORγt).
In this study, IMQ-induced IL-17A-and IL-22-producing γδ T cell and CD4+ T cell in skin-draining LNs were not reduced in IL-21R 
| CONCLUSIONS
Since Genomewide association studies identified the region encoding IL-2 and IL-21 as a susceptibility locus for psoriasis. [22, 23] , IL-21R −/− mouse; WT, wild-type mouse preferentially drive Th1 or Th17 cell pathways. [3] IL-21 production could also be positively regulated by type I IFN, because this cytokine is highly produced in psoriatic skin and it is able to induce IL-21 in other systems. [24] In contrast to the previous reports implicating IL-21 in psoriasis pathogenesis, IMQ-induced psoriatic inflammation in this study was gional LNs, [25] and IL-23-activated dermal γδ T cells were identified as a major source of IL-17 in murine skin. [26] Vγ9 Vδ2+ T cells, which are human γδ T cells, are increased in human psoriatic skin, and combinations of IL-1, IL-23, IL-6 and TGF-β promoted IL-17 production from RORγt+ Vγ9 Vδ2+ T cells. [27] γδ T cells play in autoimmune diseases as an early source of IL-17 and IL-21, initiating the responses mediated by conventional IL-17-secreting CD4+ Th17 cells, and IL-21 augments IL-17 production by γδ T cells. [28, 29] In this study, the regulates its own production in a dose-and time-dependent fashion F I G U R E 2 Upregulation of IL-17A-producing γδ T cell and CD4+ T cell in skin-draining lymph node caused by imiquimod (IMQ) application is independent of IL-21R signalling. After daily application of IMQ for 6 d, single-cell suspensions from ear-draining lymph nodes were stained with antibodies specific for IL-17A and IL-22 as well as CD3, CD4 and γδ cell surface markers. Flow cytometry demonstrated that the ratio of γδ T cell among CD3+ T cells was similar in wildtype (WT) and IL-21R −/− mice. The ratio of IL-17A-producing γδ T cell to CD4+ T cell regardless of concomitant IL-22 production was also not decreased in IL-21R −/− mice compared to WT mice. SDLN, Skin-draining lymph nodes; CNT, control; IMQ, imiquimod; IL-21R
IL-21R
−/− mouse; WT, wild-type mouse through STAT3 activation. [31, 32] Our results showed a bimodal upregulation of IL-21 at days 1 and 5 after IMQ application in WT mice 
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